Cited by 348Cancer, Hypoxia, and MetabolismCancer Cells and MetastasisAngiogenesis and VEGF in Cancer

The DOI matches its Crossref record.

Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression

Cosse, Jean-Philippe, Michiels, Carine·2008·Anti-Cancer Agents in Medicinal Chemistry

DOI 10.2174/187152008785914798

Open this paper in CoChat — free account

Abstract

A solid tumour forms an organ-like structure that is comprised of cancer cells as well as stroma cells (fibroblasts, inflammatory cells) that are embedded in an extracellular matrix and are nourished by vascular network. However, tumoral microenvironment is heterogeneous due to the abnormal vasculature network and high proliferation rate of cancer cells. Because of these features, some regions are starved from oxygen, a phenomenon called hypoxia. Transient hypoxia is associated with inadequate blood flow while chronic hypoxia is the consequence of the increased oxygen diffusion distance due to tumour expansion. Both types of hypoxia are correlated with poor outcome for patients. Moreover, hypoxia also enhances chemoresistance of cancer cells. Firstly, the delivery of drugs in hypoxic area and cellular uptake of it are affected by hypoxia or associated acidity. Secondly, some chemotherapeutic drugs require oxygen to generate free radicals that contribute to cytotoxicity. Last, hypoxia induces cellular adaptations that compromise the effectiveness of chemotherapy. In response to nutrient deprivation due to hypoxia, the rate of proliferation of cancer cells decreases but chemotherapeutic drugs are more effective against proliferating cells. On the other hand, hypoxia induces adaptation by post-translational and transcriptional changes that promote cell survival and resistance to chemotherapy. Through these changes, hypoxia promotes angiogenesis, shift to glycolytic metabolism, expression of ABC transporters, cell survival by inducing the expression of genes encoding growth factors and the modulation of apoptotic process. The aim of this review is to provide a description of known hypoxia-induced mechanisms of chemoresistance at a cellular level.

Integrity signals

Registry

Crossref · 10.2174/187152008785914798

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 201–300 of 347

Bridging Population and Tissue Scale Tumor Dynamics: A New Paradigm for Understanding Differences in Tumor Growth and Metastatic Disease
Gallaher, J. A., Babu, A., Plevritis, S. K., & Anderson, A. R. A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0759 · Cited by 17
“Hypoxic cells are also less sensitive to both radiation and chemotherapy (35, 36), so choice of treatment is affected by a tumor's oxygen profile (37).”
Normal tissue and tumor microenvironment adaptations to aerobic exercise enhance doxorubicin anti-tumor efficacy and ameliorate its cardiotoxicity in retired breeder mice
Wakefield, Z. R., Tanaka, M., Pampo, C., Lepler, S. E., Rice, L. P., Guingab-Cagmat, J. D., Garrett, T. J., & Siemann, D. W. (2021) · Oncotarget · doi:10.18632/oncotarget.28057 · Cited by 18
Synthesis and Evaluation of Multifunctional Fluorescent Inhibitors with Synergistic Interaction of Prostate-Specific Membrane Antigen and Hypoxia for Prostate Cancer
Kwon, Y., Oh, J.-M., La, M. T., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00767 · Cited by 18
Cytotoxicity analysis of etoposide and cisplatin on cell lines from human lung cancer and normal human lung
Davou, G., Nyam, C. J., Essien, U., Choji, T., Echeonwu, B., & Lugos (2019) · International Research Journal of medicine and Medical Sciences · doi:10.30918/irjmms.72.19.022 · Cited by 17
“…adaptive and resistance conditions such as hypoxic conditions which interfere with the mechanisms of action for most cancer chemotherapeutic drugs (Teicher, 1994; Cosse and Michiels, 2008; Adamski et al., 2013), leaving the normal cells more vulnerable to the cytotoxic effects of these drugs.”
Background
PRL-3 dephosphorylates p38 MAPK to promote cell survival under stress
Shi, Y. P., Xu, S., Ngoi, N. Y. L., Zeng, Q., & Ye, Z. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.015 · Cited by 18
Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
Deng, Z., Teng, Y.-J., Zhou, Q., Ouyang, Z.-G., Hu, Y., Long, H.-P., Mei-jie, H., Mei, S., Lin, F.-X., Dai, X.-J., et al. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i11.1725 · Cited by 16
Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
Tiezzi, D. G., Clagnan, W. S., Mandarano, L. R. M., de Sousa, C. B., Marana, H. R. C., Tiezzi, M. G., & de Andrade, J. M. (2013) · Clinics · doi:10.6061/clinics/2013(05)03 · Cited by 17
Novel multifunctional 18F-labelled PET tracer with prostate-specific membrane antigen-targeting and hypoxia-sensitive moieties
Kwon, Y., Lee, J. Y., La, M. T., Lee, S. J., Lee, S. H., Park, J. H., & Kim, H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112099 · Cited by 17
In silico analysis of hypoxia activated prodrugs in combination with anti angiogenic therapy through nanocell delivery
Meaney, C., Rhebergen, S., & Kohandel, M. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007926 · Cited by 17
“…tumours resulting from an inadequate oxygen supply and has been associated with many negative cancer behaviours including increased metastasis and aggressive phenotypes, promotion of genetic instability, and decreased treatment effectiveness for immunotherapy, radiotherapy, and chemotherapy [1–11].”
Efficacy of atovaquone on EpCAM+CD44+ HCT‑116 human colon cancer stem cells under hypoxia
Fu, C., Xiao, X., Xu, H., et al. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9416 · Cited by 17
“Tumor hypoxia was observed to diminish the efficacy of several chemotherapeutic drugs (28).”
Background
Autophagic responses to hypoxia and anticancer therapy in head and neck cancer
Wu, H., Huang, S., & Zhang, D. (2014) · Pathology - Research and Practice · doi:10.1016/j.prp.2014.11.010 · Cited by 17
BNIP3 Upregulation Characterizes Cancer Cell Subpopulation With Increased Fitness and Proliferation
Zhu, Y., Chen, B., Yan, J., Zhao, W., Dou, P., Sun, N., Wang, Y., & Huang, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.923890 · Cited by 15
“The hypoxic niches typically render chemotherapy (17) or radiation therapy (18) ineffective.”
Background
Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma
Guo, W., Luo, D., Chen, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12952 · Cited by 16
“Past studies of pre-treatment DCE-MRI showed that hypoxia or low perfusion pre-therapy are markers of poor response and prognosis, however mostly focused on quantitative metrics [18-25].”
Background
Pharmacokinetic modeling of a novel hypoxia PET tracer [18F]HX4 in patients with non-small cell lung cancer
Verwer, E. E., Zegers, C. M. L., van Elmpt, W., et al. (2016) · EJNMMI Physics · doi:10.1186/s40658-016-0167-y · Cited by 16
“Tumor targeted therapy strategies, such as radiation therapy and many types of chemotherapy, require the presence of oxygen in the cell [2, 3].”
Background
Synthesis of maleimide-based enediynes with cyclopropane moieties for enhanced cytotoxicity under normoxic and hypoxic conditions
Wang, W., Lu, H., Zhang, M., et al. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00142f · Cited by 16
Peroxide mediated oxygen delivery in cancer therapy
Khorshidi, S., Younesi, S., & Karkhaneh, A. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112832 · Cited by 19
Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ
Rêgo, M. J. B. D. M., de Mello, G. S. V., Santos, C. A. D. S., et al. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0013-4 · Cited by 16
“The hypoxic response via hypoxia inducible factor (HIF) is recognized as one of the most important microenvironmental modulator, altering tumor behavior and influencing all tumors hallmarks, enabling tumors cells to acquire an aggressive phenotype and become resistant to chemotherapy and radiotherapy [5, 6].”
Background
Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine
Barajas, R., Krohn, K., Link, J., Hawkins, R. A., Clarke, J. L., Pampaloni, M. H., & Cha, S. (2016) · Biomedicines · doi:10.3390/biomedicines4040024 · Cited by 16
“Chronic hypoxia has been established to infer radioresistance, promote metastatic spread, and chemotherapy resistance for neoplastic cells [38,39].”
Background
Gestational Hypoxia and Programing of Lung Metabolism
Rood, K., Lopez, V., Frano, M. R. L., Fiehn, O., Zhang, L., Blood, A. B., & Wilson, S. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01453 · Cited by 15
“The influence of high altitude gestation on metabolism is important to consider as the ensuing chronic hypoxia reduces oxygen uptake and delivery to immature fetal tissues (Cosse and Michiels, 2008).”
Background
Cellular reprogramming, chemoresistance, and dietary interventions in breast cancer
Pereira, I. C., Mascarenhas, I. F., Capetini, V. C., Ferreira, P. M. P., Rogero, M. M., & Torres‐Leal, F. L. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103796 · Cited by 17
Why electroporation is a useful technique for cancer treatments
Haltiwanger, S. (2014) · Elsevier eBooks · doi:10.1533/9781908818294.103 · Cited by 15
Doxorubicin selectively suppresses mRNA expression and production of endothelin-1 in endothelial cells
Keltai, K., Cervenak, L., Makó, V., et al. (2010) · Vascular Pharmacology · doi:10.1016/j.vph.2010.08.001 · Cited by 14
Development and validation of a prognostic nomogram for the pre-treatment prediction of early metachronous metastasis in endemic nasopharyngeal carcinoma: a big-data intelligence platform-based analysis
Zhang, L., Xu, F., He, W., Huang, M., Song, D., Li, Y., Deng, Q., Huang, Y.-S., Wang, T., & Shao, J. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920978132 · Cited by 15
Pretreatment anemia and survival in nasopharyngeal carcinoma
Zhang, L., Tang, J., Lan, X., OuYang, P., & Xie, F. (2015) · Tumor Biology · doi:10.1007/s13277-015-4042-6 · Cited by 14
“Tumor hypoxia has been acknowledged to play a particularly important role in causing radioresistance [5] and chemoresistance [6].”
Background
Synthesis and evaluation of indium-111-labeled imidazothiadiazole sulfonamide derivative for single photon emission computed tomography imaging targeting carbonic anhydrase-IX
Iikuni, S., Okada, Y., Shimizu, Y., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127255 · Cited by 14
Exploiting tumor hypoxia for cancer treatment
Niemans (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180626rn · Cited by 14
Enzymatic activation of indolequinone-substituted 5-fluorodeoxyuridine prodrugs in hypoxic cells
Jiho, Y., Kurihara, R., Kawai, K., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.04.003 · Cited by 13
Antitumor potential of anethole singly and in combination with cyclophosphamide in murine Sarcoma-180 transplantable tumor model
Jana, S., Patra, K., Mukherjee, G., Bhattacharjee, S., & Mandal, D. P. (2015) · RSC Advances · doi:10.1039/c5ra07230a · Cited by 13
Using Stable Free Radicals to Obtain Unique and Clinically Useful DataIn Vivoin Human Subjects
Swartz, H. M. (2016) · Radiation Protection Dosimetry · doi:10.1093/rpd/ncw323 · Cited by 13
Reduction in mitochondrial oxidative stress mediates hypoxia-induced resistance to cisplatin in human transitional cell carcinoma cells
Kim, M., Hwang, S., Yang, Y., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.05.013 · Cited by 12
Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells
Caron, J. M., & Caron, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141565 · Cited by 12
“Over time hypoxia induces resistance to the beneficial effects of many current chemotherapeutic drugs and radiation therapy [59,60].”
Background
Antagonism in effectiveness of evofosfamide and doxorubicin through intermolecular electron transfer
Anderson, R. F., Li, D., & Hunter, F. W. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.385 · Cited by 11
“Hypoxia arises early in the course of tumour development and selects for the outgrowth of clones that are resistant to apoptosis [2], genetically unstable [3] and refractory to some widelyused chemotherapeutic agents [4].”
Background
Modulating sphingosine‐1‐phosphate receptors to improve chemotherapy efficacy against Ewing sarcoma
Marmonti, E., Savage, H., Zhang, A., Bedoya, C. A. F., Morrell, M. B. G., Harden, A., Buzbee, M., & Schadler, K. (2020) · International Journal of Cancer · doi:10.1002/ijc.32862 · Cited by 12
Synergistic enhancement of ultrasound therapy for tumors using hypoxia-activated 6-diazo-5-oxo-L-norleucine (DON) prodrug nanoparticles
Zheng, M., Liu, Z., Xu, H., Ye, D., Cui, L., Yang, C., Ma, L., Wang, K., Sakurai, K., & Tang, Z. (2024) · Nano Research · doi:10.1007/s12274-024-6534-4 · Cited by 12
U-Shape Pillar Strip for 3D Cell-Lumped Organoid Model (3D-COM) Mimicking Lung Cancer Hypoxia Conditions in High-Throughput Screening (HTS)
Lee, S., Lee, E., Lim, J. U., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00890 · Cited by 13
Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model
Pedrosa, L. R. C., van Tellingen, O., Soullié, T., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.003 · Cited by 11
Identification and validation of a prognostic signature related to hypoxic tumor microenvironment in cervical cancer
Nie, C., Qin, H., & Zhang, L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269462 · Cited by 12
“Moreover, hypoxia could enhance the resistance to chemotherapy through a series of signaling biological processes, such as DNA damage, apoptosis, p53, autophagy and mitochondrial activity [7, 44, 45].”
Background
Identification of Ovarian Cancer Patients Most Likely to Achieve Chemotherapy Response Score 3 Following Neoadjuvant Chemotherapy: Development of a Predictive Nomogram
Liang, W., Li, H., Wu, J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.560888 · Cited by 11
Red ginseng represses hypoxia-induced cyclooxygenase-2 through sirtuin1 activation
Lim, W., Shim, M. K., Kim, S., & Lee, Y. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.03.005 · Cited by 11
Engineering Tools for Regulating Hypoxia in Tumour Models
Kim, M. H., Green, S. D., Lin, C., & Koenig, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16759 · Cited by 9
Hypoxia-Responsive Azobenzene-Linked Hyaluronate Dot Particles for Photodynamic Tumor Therapy
Lee, S., Kim, Y., & Lee, E. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050928 · Cited by 10
Breast Cancer Subtypes Based on Hypoxia-Related Gene Sets Identify Potential Therapeutic Agents
Xiong, Z., Huang, W., Zhong, W., Fu, J., Feng, J., Wang, X., & Ling, F. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.900005 · Cited by 10
Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin
Kulsoom, B., Shamsi, T. S., & Afsar, N. A. (2018) · Cancer Management and Research · doi:10.2147/cmar.s181299 · Cited by 10
“In patients with colorectal carcinoma (n=228), Topo-IIa overexpression was found associated with advanced tumor stage and resistant disease.(23) However, some studies could not find any significant association of Topo-IIa expression with outcome or survival among AML (n=123, semiquantitative RT-PCR)(28) and breast can…”
Background
The Combination of Active‐Targeted Photodynamic Therapy and Photoactivated Chemotherapy for Enhanced Cancer Treatment
Nkune, N. W., & Abrahamse, H. (2025) · Journal of Biophotonics · doi:10.1002/jbio.70005 · Cited by 9
“PACT is oxygen-independent, which makes it suitable for treating hypoxic tumors [77, 78].”
Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir
Gringmuth, M., Walther, J., Greiser, S., Toussaint, M., Schwalm, B., Kool, M., Kortmann, R., Glasow, A., & Patties, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073815 · Cited by 9
“This goes along with the observed reduction of proliferating cells (Figure 6a) and suggests that a shortage of nutrients and/or oxygen might led to more quiescent, non-proliferative tumor cells [67].”
Background
Cellular signaling in the hypoxic cancer microenvironment: Implications for drug resistance and therapeutic targeting
Bakshi, H. A., Mkhael, M., Hakkim, F. L., Khan, A. U., Aljabali, A. A. A., Mishra, V. K., El‐Tanani, M., Charbe, N. B., & Tambuwala, M. M. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110911 · Cited by 10
Direct inhibition of tumor hypoxia response with synthetic transcriptional repressors
Qiao, Z., Nguyen, L. C., Yang, D., Dann, C., Thomas, D. M., Henn, M. A., Valdespino, A., Swenson, C., Oakes, S. A., Rosner, M. R., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01716-z · Cited by 11
“HIF1α specifically has been shown to correlate with the size 16,17 and growth of human TNBC xenografts 17,50 and hypoxia-induced gene signatures have also been associated with poor disease outcomes in TNBC patients 17,51,52 .”
Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells
Joe, N. S., Wang, Y., Oza, H. H., Godet, I., Milki, N., Riggins, G. J., & Gilkes, D. M. (2023) · Cancers · doi:10.3390/cancers15041330 · Cited by 9
“A common feature of solid tumors is hypoxia, or an imbalance in O2 consumption and demand, which causes an overall decrease in O2 levels in the microenvironment [18,19].”
Background
Synergic effect between 5-fluorouracil and celecoxib on hypoxic gastric cancer cells
Zhang, X., Sun, X., Liu, W., Feng, Y., Zhang, H., SHI, L.-H., SUN, X.-N., Li, Y., & GAO, Z.-X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2783 · Cited by 9
Single-Cell Analysis Reveals Early Manifestation of Cancerous Phenotype in Pre-Malignant Esophageal Cells
Wang, J., Shi, X., Johnson, R. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075365 · Cited by 9
Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling
Sim, J. J., Park, M., Baek, J., Lee, H., Jeong, K., & Kim, H. M. (2018) · Anticancer Research · doi:10.21873/anticanres.12772 · Cited by 9
Disorders of Blood Cell Production in Clinical Oncology
Glaspy, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00034-5 · Cited by 9
Power-Doppler-based NH002 microbubble sonoporation with chemotherapy relieves hypoxia and enhances the efficacy of chemotherapy and immunotherapy for pancreatic tumors
Wu, S., Wang, C., Kang, S., Yu, C., Chen, F.-H., & Chiang, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-54432-y · Cited by 9
“The highly proliferative tumor cells and inadequate blood supply lead to hypoxia within TME, thus hindering the delivery and therapeutic efficacy of chemical drugs 46 .”
Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
Perfahl, H., Jain, H. V., Joshi, T. V., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65012-1 · Cited by 8
CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer
Wang, Y.-Z., Qian, Y.-C., Yang, W., Ye, L.-H., Guo, G.-D., Lv, W., Huan, M., Feng, X., Wang, K., Zhao, Y., et al. (2023) · Asian Journal of Andrology · doi:10.4103/aja202287 · Cited by 8
TRP Channels: The Neglected Culprits in Breast Cancer Chemotherapy Resistance?
Soussi, M., Hasselsweiller, A., & Gkika, D. (2023) · Membranes · doi:10.3390/membranes13090788 · Cited by 7
“Some drugs’ cytotoxic effects depend on oxygen availability, reducing their efﬁcacy under hypoxic conditions [16].”
Carbon nanotubes conjugated with cisplatin activate different apoptosis signaling pathways in 2D and 3D-spheroid triple-negative breast cancer cell cultures: a comparative study
Badea, M. A., Balaș, M., Ioniță, D., & Dinischiotu, A. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03779-2 · Cited by 9
“Furthermore, as hypoxic niches can alter drug uptake, the responsiveness of 3D cultures can also be linked to limited drug penetration (Cosse and Michiels 2008).”
Background
Effect of hypoxia on chemosensitivity to 5-fluorouracil in SH-SY5Y neuroblastoma cells
Warren, H. R., & Hejmadi, M. V. (2016) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzw005 · Cited by 7
Applying Tools From Evolutionary Biology to Cancer Research
Enríquez‐Navas, P. M., & Gatenby, R. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804310-3.00014-4 · Cited by 7
Prognostic impact of cigarette smoking on the survival of patients with established esophageal squamous cell carcinoma receiving radiotherapy: A retrospective study from southern China
Zou, G., Su, Z. Z., Li, J., Xie, F., & Li, Q. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7356 · Cited by 7
“Tumor hypoxia is well known to influence the reaction to radiation and chemotherapy (21,22).”
Background
Rational design of nanoliposomes by tuning their bilayer rigidity for the controlled release of oxygen
Hong, J., Yoon, S., Choi, Y., et al. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.121003 · Cited by 7
Various doses of fractioned irradiation modulates multidrug resistance 1 expression differently through hypoxia-inducible factor 1α in esophageal cancer cells
Zhang, G.-J., Gao, R., Wang, J.-S., Fu, J.-K., Zhang, M., & Jin, X. (2011) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2010.01168.x · Cited by 7
Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model
Baird, A., Gray, S. G., Richard, D. J., & O'Byrne, K. J. (2016) · Scientific Reports · doi:10.1038/srep18907 · Cited by 7
Therapeutic effect of combined hyperbaric oxygen and radiation therapy for single brain metastasis and its influence on osteopontin and MMP‑9
Tao, J., Gao, Z., Huang, R., et al. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6930 · Cited by 7
The regulation of microRNAs on chemoresistance in triple-negative breast cancer: a recent update
Yan, L.-J., Lau, A. T. Y., & Xu, Y. (2024) · Epigenomics · doi:10.2217/epi-2023-0430 · Cited by 6
Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
Basudhar, D., Miranda, K. M., Wink, D. A., & Ridnour, L. A. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-30705-3_15 · Cited by 6
Radioresistance Mechanisms in Head and Neck Cancer
Nguyen, Q., & Koo, B. S. (2025) · Clinical and Experimental Otorhinolaryngology · doi:10.21053/ceo.2025-00029 · Cited by 5
“Oxygen can only effectively diffuse approximately 100–140 microns from blood vessels; thus, rapidly growing tumors quickly surpass their blood supply, developing hypoxic and necrotic cores observed in approximately 90% of solid tumors [109].”
“Anemia and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients”
Danzinger, S., Fügerl, A., Pfeifer, C., et al. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.1928166 · Cited by 5
Integrative oncology drug discovery accompanied by preclinical translational research as prerequisite for clinical development.
Hoffmann, J. (2014) · PubMed · doi:10.3978/j.issn.2304-3865.2014.05.09 · Cited by 5
Role of MSCs in Antitumor Drug Resistance
Naour, A. L., & Couderc, B. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803102-5.00013-6 · Cited by 6
Sense and Sensibility of Oxygen in Pathophysiology Using EPR Oximetry
Kuppusamy, P. (2020) · Biological magnetic resonance · doi:10.1007/978-3-030-47318-1_9 · Cited by 6
Pseudo-Temporal Dynamics of Chemo-Resistant Triple-Negative Breast Cancer Cells Reveal EGFR/HER2 Inhibition as Synthetic Lethal During Mid-neoadjuvant Chemotherapy
Song, W., Chia, P. L., Zhou, X., Walsh, M. J., Silva, J., & Zhang, B. (2022) · iScience · doi:10.1016/j.isci.2023.106064 · Cited by 5
“Also, the enrichment of hypoxia pathways was unique to C2, indicating the basal-like trajectory captures the hypoxic niche of chemoresistance.(59) Thus, unlike the Her2-like cells expanding in midNAC, the basal-like, post-treatment cells in trajectory-III/C2 may not depend on EGFR signaling and require entirely differ…”
Background
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers
Barbato, A., Piscopo, F., Salati, M., Pollastro, C., Evangelista, L., Ferrante, L., Limongello, D., Brillante, S., Iuliano, A., Bonetti, L. R., et al. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01332-0 · Cited by 5
A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
Xiang, J., He, Y., Li, Y., Wu, K., Cheng, M., Wang, Y., & Chen, R. (2022) · Cancer Medicine · doi:10.1002/cam4.5102 · Cited by 5
Effect of PTEN and KAI1 gene overexpression on the proliferation, metastasis and radiosensitivity of ASPC-1 pancreatic cancer cells under hypoxic conditions
Li, H., Li, J., Liu, X., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2404 · Cited by 5
“Hypoxia may also reduce the efficacy of radiotherapy, chemotherapy and other therapeutic approaches (3).”
AAnet Resolves a Continuum of Spatially Localized Cell States to Unveil Intratumoral Heterogeneity
Venkat, A., Youlten, S. E., Juan, B. P. S., Purcell, C. A., Gupta, S., Amodio, M., Neumann, D., Lock, J. G., Westacott, A. E., McCool, C. S., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0684 · Cited by 9
“In the clinical setting, a hypoxic phenotype is highly associated with TNBC compared with other breast cancer subtypes and is associated with cellular senescence and poor response to chemotherapy (37, 38).”
Chemotherapy-Induced Anemia in Adults Incidence and Treatment
Ali, S. N., Shallal, A. F., Qader, İ. N., et al. (2024) · Journal of Bursa Faculty of Medicine · doi:10.61678/bursamed.1436846 · Cited by 4
The glycomic profile of invasive ductal carcinoma of the breast is altered in patients with hypoxic regions: implications for tumor behavior
Rêgo, M. J. B. D. M., Filho, A. F. D. S., Cordeiro, M. F., et al. (2014) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2014.0017 · Cited by 4
“Cells that survive in this adverse environment are typically resistant to radiotherapy and chemotherapy and differ from cells in areas with adequate blood supply [3, 4].”
Background
Effects of obatoclax combined with gemcitabine on the biological activity of pancreatic cancer cells under hypoxic conditions
Hou, X., Li, S., Wu, C., Li, K., Xu, S., & Wang, J. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8932 · Cited by 4
Purinergic Receptors: Novel Targets for Cancer Immunotherapy
Vijayan, D., Smyth, M. J., & Teng, M. W. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_7 · Cited by 4
Establishment of Prognosis Model in Acute Myeloid Leukemia Based on Hypoxia Microenvironment, and Exploration of Hypoxia-Related Mechanisms
Zhong, J., Wu, H., Bu, X., Li, W., Cai, S., Du, M., Gao, Y., & Ping, B. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.727392 · Cited by 4
Hypoxia-triggered autophagy modulates cisplatin resistance in non-small cell lung Cancer via EIF2AK3-dependent PI3K/AKT signaling and mTOR-independent mechanisms
Fu, J., Xu, W. G., Wang, G., Zeng, L., Xian, L., Wei, Y., & Zhang, J. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02893-z · Cited by 3
“Hypoxia occurs in 90% of solid tumors due to insuf ﬁ cient oxygen supply from angiogenesis to rapidly growing tumor masses [13, 14].”
WITHDRAWN: Hypoxia-induced STAT3 contributes to chemoresistance and epithelial–mesenchymal transition in prostate cancer cells
Liu, Z., Han, Y., Fang, J., Hu, F., Zhang, X., & Xu, Q. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.027 · Cited by 3
Evaluation of 18F-EF5 for detection of hypoxia in localized adenocarcinoma of the prostate
Wadsworth, B. J., Decotret, L. R., Villamil, C. F., Yapp, D. T. T., Wilson, D. C., Bénard, F., McKenzie, M., & Bennewith, K. L. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1959636 · Cited by 3
Nanomodulation and nanotherapeutics of tumor-microenvironment
Dubey, R., Garg, S. S., & Gupta, J. (2022) · OpenNano · doi:10.1016/j.onano.2022.100099 · Cited by 3
Chemoresistance factors in non-small cell lung cancer
Шевченко, А. И., Колесник, А. П., Каджоян, А. В., et al. (2016) · Pathologia · doi:10.14739/2310-1237.2016.1.71945 · Cited by 3
To breathe or not to breathe? Hypoxia after pulsed-electric field treatment reduces the effectiveness of electrochemotherapy in vitro
Šilkūnas, M., Bavirša, M., Saulė, R., Batiuškaitė, D., & Saulis, G. (2020) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2020.107636 · Cited by 3
Anemia in oncology
Sushinskaya, T. V., Li, E.-S., & Stuklov, N. (2021) · P A Herzen Journal of Oncology · doi:10.17116/onkolog20211001164 · Cited by 3
‘Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research’
Passalacqua, M. I., Rizzo, G., Santarpía, M., & Curigliano, G. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2159805 · Cited by 4
“Hypoxia induces breast cancer stem cells (CSCs) phenotype and promotes immunosuppression [107].”
Background
CD39 is induced by nutrient deprivation in colorectal cancer cells and contributes to the tolerance to hypoxia
Ning, Z., Liu, K., & Xiong, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150367 · Cited by 3
Overexpression of Carbonic Anhydrase IX is a Dismal Prognostic Marker in Breast Carcinoma in Egyptian Patients
Samaka, R. M., El‐Wahed, M. M. A., Al‐Sharaky, D. R., et al. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000208 · Cited by 3
The pH-centered paradigm in cancer
Koltai, T., Reshkin, S. J., & Harguindey, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819059-3.00003-4 · Cited by 3
Hypoxic response is driven by the BAF form of SWI/SNFPreprint
Tran, K. D., Chakravarty, T., Garzon, J. L., Saraf, A., Florens, L. A., Washburn, M. P., & Dutta, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.16.480689 · Cited by 2
A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapy
Menegakis, A., Vennin, C., Ient, J., Groot, A. J., Krenning, L., Klompmaker, R., Friskes, A., Ilić, M., Yaromina, A., Harkes, R., et al. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110592 · Cited by 2
Coenzyme Q10 as an Inhibitor of Effector Release from One-Electron-Reduced Bioreductive Anticancer Prodrugs
Anderson, R. F., & Qi, W. (2025) · Molecules · doi:10.3390/molecules30040760 · Cited by 2
Natural Compounds and their Nano-formulations in Combating Autophagy-mediated Drug Resistance in Human Cancers
Khan, F., Chauhan, P. K., Ramniwas, S., Verma, M., Pandey, S., Ballal, S., Kumar, S., Bhat, M., Sharma, S., Kumar, M., et al. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266345188250304064600 · Cited by 2
The Possible Role of GPI-Ceruloplasmin in Hypoxia De Novo Creation and Maintenance
Arrigoni, R. (2013) · Advances in Biochemistry · doi:10.11648/j.ab.20130102.13 · Cited by 2
“Hypoxia is a pivotal driving force of malignant progression [7]: it is well known that can induce tumor metastasis [1].”
Background
Angiogenesis, Arteriogenesis, and Mitochondrial Dysfunction
McMurtry, M. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-5930-9_15 · Cited by 2
Analysis of the translatome in solid tumors using polyribosome profiling/RNA-Seq
Adjibade, P., St-Sauveur, V. G., Droit, A., Khandjian, É. W., Toren, P., & Mazrouï, R. (2016) · Journal of Biological Methods · doi:10.14440/jbm.2016.151 · Cited by 2
“Resistant tumor cells including cancer-stem cells can however survive these inadequate nutrient and oxygen accessibility stressful environments in part via activation of stress-based adaptive translational mechanisms [14,15].”
Background
Combination effects of sorafenib with PI3K inhibitors under hypoxia in colorectal cancer
Bhatia, D. R., & Thiagarajan, P. (2016) · Hypoxia · doi:10.2147/hp.s115500 · Cited by 2

Authors: Cosse, J.-P., & Michiels, C.
Affiliations: University of Namur (BE)
Corresponding author: Michiels, Carine
ORCID: Michiels, Carine
Venue: Anti-Cancer Agents in Medicinal Chemistry
Publisher: Bentham Science Publishers Ltd.
Published: 2008-10-01
Volume: 8
Issue: 7
Pages: 790-797
ISSN: 1568-0118 (ISSN-L)
1871-5206
DOI: 10.2174/187152008785914798
OpenAlex: W2044149912
Cited by: 348
References: 0
Citations by year: 2026: 4 · 2025: 10 · 2024: 16 · 2023: 19 · 2022: 27 · 2021: 32 · 2020: 33 · 2019: 21 · 2018: 24 · 2017: 23 · 2016: 25 · 2015: 25 · 2014: 15 · 2013: 20 · 2012: 14
FWCI: 4.44
Type: journal article
Language: en
Open access: closed
Locations: Anti-Cancer Agents in Medicinal Chemistry (publishedVersion)
PubMed (publishedVersion)
Digital Access to Libraries (submittedVersion)
ORBi (University of Liège) (submittedVersion)
Repository of the University of Namur (submittedVersion)
Funders: Fonds De La Recherche Scientifique - FNRS
Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords: tumor hypoxia, chemoresistance, tumor microenvironment, tumor stroma, tumor vasculature, transcriptional adaptation, angiogenesis, glycolytic metabolism, ABC transporters, apoptosis, tumor progression
MeSH terms: Animals, Autophagy, Humans, Neoplasm Invasiveness, Neoplasms, Neovascularization, Pathologic, Cell Hypoxia, Tumor Suppressor Protein p53, Disease Progression, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-bcl-2, Angiogenesis Inhibitors, Cell Proliferation, Hypoxia-Inducible Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks